July 6, 2023 Comments Off on New patent for Oncopeptides Ab drug PEPAXTO Posted in: Patent Added Annual Drug Patent Expirations for PEPAXTO Pepaxto is a drug marketed by Oncopeptides Ab and is included in one NDA. There are six patents protecting this drug. This drug has…
The post New patent for Oncopeptides Ab drug PEPAXTO appeared first on DrugP…
July 6, 2023 Comments Off on New tentative approval for Mylan Labs drug posaconazole Posted in: General Biotechnology [](//www.DrugPatentWatch.com/p/preview/generic-api/posaconazole?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Posaconazole is the ge…
